Today's Hours: 8:00am - 10:00pm

Search

Did You Mean:

Search Results

  • Book
    edited by Ajay Kumar Mishra.
    Contents:
    Nanomedicine
    High-technology therapy using biomolecules or synthetic compounds for hiv inhibition
    Emerging nanomedicine approaches for osteochondral tissue regeneration
    Synthesis of poly(methacrylate) encapsulated magnetite nanoparticles via phosphonic acid anchoring chemistry and its applications toward biomedicine
    Potentiometric PVC membrane sensors and their analytical applications in pharmaceuticals and environmental samples at micro- and nano-level
    Bioceramics: silica-based organic-inorganic hybrid materials for medical applications
    Recent advances of multifunctional nanomedicines
    Nanomedicinal approaches for diabetes management
    Polymeric nanofibers in regenerative medicine
    Drug delivery and therapeutics
    Multifunctional nano/micro polymer capsules as potential drug delivery and imaging agents
    Nanophosphors-nanogold immunoconjugates in isolation of biomembranes and in drug delivery
    Cyclodextrin-based nanoengineered drug delivery system
    Medicinal patches and drug nanoencapsulation: a noninvasive alternative
    Dendrimers: a class of polymer in the nanotechnology for drug delivery
    Designing nanocarriers for drug delivery
    Multifunctional polymeric micelles for drug delivery and therapeutics
    Nanoparticles-based carriers for gene therapy and drug delivery.
    Digital Access Wiley 2013
  • Article
    Brotman HF.
    J Exp Zool. 1977 Apr;200(1):125-36.
    The inductive capacities of 9- to 16-day anterior foot dermis of scaleless low line and normal embryos were compared by recombining them with a common source of epidermis, i.e., 7-day normal back epidermis. Tissue recombinants were cultured as grafts to the chorioallantoic membrane (CAM). Both normal and scaleless low line dermis of 12 to 13 days of incubation began to lose their ability to elicit feather production in 7-day normal back epidermis. Normal foot dermis began to elicit scale production at 12 to 13 days, whereas scaleless low line anterior foot dermis maintained feather production at a low level. It is inferred that without being associated with scale placode formation, scaleless low line anterior foot dermis does not acquire specific inductive capacities related to the production of an outer scale surface in the overlying epidermis. Feather placodes do not function as surrogates of scale placodes. The difference between normal and scaleless low line anterior foot dermis in terms of specific inductive capacities related to scale production is interpreted as a secondary effect of the action of the scaleless allele in interfering with scale placode formation in the scaleless low line anterior foot epidermis.
    Digital Access Access Options